Authors
I Kone-Paut, M Darce-Bello, F Shahram, S Ozen, Rolando Cimaz, K Bouayed, M Hofer, M Gattorno, J Anton, L Cantarini, A Faye, I Tugal-Tuktun, J Kuemmerle-Deschner, S Benamour, A Arnoux, M Piram
Publication date
2013/6/1
Journal
Annals of the Rheumatic Diseases
Volume
72
Issue
Suppl 3
Pages
A739-A739
Publisher
BMJ Publishing Group Ltd
Description
Background
BD is rarely encountered in children where the disease is very difficult to recognize. The outcome of patients with few symptoms is currently unknown
Objectives
To define the outcome of paediatric patients with at least two symptoms of BD, and to obtain an appropriate definition of BD in patients <16y
Methods
An international expert committee has defined the criteria of inclusion. New patients or patients followed for a maximum of 3 years, who presented at least 2 symptoms of BD (among a list), and gave their informed consent were included, reviewed yearly.
Results
223 patients (SR: 1), from 22 centres of 12 countries, were included since 2008, median age of 13,3y (2.3-21y). Median age at first symptom was 8y (9m-18y). Family history of BD was present in 50 (22.4%) and consanguinity in 10 (4.5%). Median disease duration at inclusion was 4.7y (0-16,5y) and from the first symptom to last visit was 5.5y …